FLT3LG and neoplasm: Furthermore, FLT3 ligand (Flt3L) production by NK cells enhances cDC1 proliferation and survival in the TME, whilst IFN-γ and TNFα secretion by NK cells increased tumor antigen cross-presentation by cDC1s [45].